Literature DB >> 1826488

Expandable venous stents for treatment of the Budd-Chiari syndrome.

R R Lopez1, K G Benner, L Hall, J Rösch, C W Pinson.   

Abstract

The goals of treatment of the Budd-Chiari syndrome are relief of portal hypertension, relief of inferior vena cava syndrome, if present, and preservation of hepatic function. This study presents a patient with clinical resolution of the Budd-Chiari syndrome after placement of expandable metallic stents in the inferior vena cava and hepatic veins. A 26-year-old man with severe ascites and lower extremity edema but with relatively preserved hepatic function had a small gradient across a suprahepatic caval web, large gradients across an intrahepatic caval stenosis and the left hepatic vein, and an occluded right hepatic vein. Under angiographic control, web and caval stenosis were balloon-dilated, and modified Gianturco expandable metallic stents were placed in the intrahepatic vena cava. The left hepatic vein was dilated twice and a stent was placed. All gradients were completely eliminated. There were no complications and after 1 year, the stents have fully expanded without migration, edema and ascites have resolved, hepatic function has normalized, and the patient has returned to work. This new technique provides a simple, safe, effective, relatively inexpensive, and potentially long-lasting treatment for selected patients with the Budd-Chiari syndrome.

Entities:  

Mesh:

Year:  1991        PMID: 1826488

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Transjugular intrahepatic portocaval shunt (TIPS) and hepatic vein-to-caval stenting as salvage treatment of portal hypertension secondary to neoplasm.

Authors:  R P Davies; G R Sissons; N A McIntosh
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Mar-Apr       Impact factor: 2.740

2.  Treatment of Budd-Chiari syndrome by metallic stent as a bridge to liver transplantation.

Authors:  L Martin; R F Dondelinger; G Trotteur
Journal:  Cardiovasc Intervent Radiol       Date:  1995 May-Jun       Impact factor: 2.740

3.  Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome.

Authors:  M D Uhl; D B Roth; C A Riely
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 4.  Balloon dilation of inferior vena cava stenosis causing hemodialysis graft failure.

Authors:  G Rozenblit; K M Butt
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

Review 5.  The use and misuse of transjugular intrahepatic portasystemic shunts.

Authors:  A J Sanyal
Journal:  Curr Gastroenterol Rep       Date:  2000-02

6.  Selective management of hepatic venous outflow obstruction.

Authors:  G G Tsiotos; D M Nagorney
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

7.  Inferior vena cava stenting: a safe and effective treatment for intractable ascites in patients with polycystic liver disease.

Authors:  Jayleen Grams; Swee H Teh; Vicente E Torres; James C Andrews; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

8.  Percutaneous hepatic venous reanastomosis in a patient with Budd-Chiari syndrome.

Authors:  B L Dolmatch; B S Cooper; P P Chang; R J Gray; K M Horton
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

9.  Budd-Chiari Syndrome.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

10.  Budd-Chiari syndrome due to antithrombin III deficiency.

Authors:  Amit Jagtap; Preeti Shanbag; Mamta Vaidya
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 5.319

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.